Skip to main content

Table 5 Association between age and coagulation marker levels in ARDS patients (mediation step 3)

From: Increased mortality in elderly patients with acute respiratory distress syndrome is not explained by host response

 

Coefficient [95% CI]

p value

Coefficient [95% CI]*

p value

Adjusted R2

Platelet factor 4

 Young adults

Reference

NA

Reference

NA

0.138

 Middle-aged adults

0.26 [− 0.24, 0.76]

0.313

0.26 [− 0.21, 0.74]

0.262

 

 Elderly

0.59 [0.05, 1.08]

0.033

0.36 [− 0.14, 0.87]

0.129

 

d-Dimer

 Young adults

Reference

NA

Reference

NA

0.031

 Middle-aged adults

− 0.02 [− 0.22, 0.19]

0.857

− 0.01 [− 0.22, 0.20]

0.942

 

 Elderly

0.02 [− 0.19, 0.23]

0.829

0.03 [− 0.19, 0.24]

0.870

 

Tissue plasminogen activator

 Young adults

Reference

NA

Reference

NA

0.063

 Middle-aged adults

0.05 [− 0.15, 0.26]

0.520

0.08 [− 0.13, 0.28]

0.459

 

 Elderly

0.18 [− 0.04, 1.39]

0.103

0.24 [0.02, 0.45]

0.032

 

PAI-1

 Young adults

Reference

NA

Reference

NA

0.141

 Middle-aged adults

− 0.31 [− 0.64, 0.03]

0.072

− 0.21 [− 0.54, 0.10]

0.141

 

 Elderly

− 0.33 [− 0.68, 0.01]

0.054

− 0.21 [− 0.54, 0.12]

0.177

 

Protein C

 Young adults

Reference

NA

Reference

NA

0.035

 Middle-aged adults

− 0.00 [− 0.09, 0.09]

0.989

0.00 [− 0.09, 0.09]

0.973

 

 Elderly

− 0.05 [− 0.15, 0.04]

0.265

− 0.07 [− 0.17, 0.03]

0.204

 

Anti-thrombin

 Young adults

Reference

NA

Reference

NA

0.066

 Middle-aged adults

− 0.00 [− 0.13, 0.12]

0.992

0.01 [− 0.12, 0.13]

0.850

 

 Elderly

− 0.04 [− 0.82, 0.09]

0.564

− 0.03 [− 0.16, 0.10]

0.295

 
  1. Data is presented as beta-coefficient (β) with a 95% confidence interval [CI]. All biomarkers are log-transformed. *Adjusted for ethnic background, gender, admission type, readmission, direct hit for ARDS, Charlson Comorbidity Index, APACHE-IV score adjusted for age, immunodeficiency, tidal volume per predicted body weight, positive end-expiratory pressure. A p value < 0.05 was considered as statistically significant. PAI-1, plasminogen activator inhibitor-1. Goodness of fit, adjusted R2. NA not applicable